Analysis reveals composition of counterfeit pills in Rhode Island’s illicit drug supply

Plus, news about Rivus and Crown Labs: Two Chi­nese biotechs file for stock list­ings in Hong Kong: Shang­hai Bao Phar­ma­ceu­ti­cals and Sichuan Biokin Phar­ma­ceu­ti­cal join

Ei­sai and Bio­gen said Tues­day that they start­ed an ap­pli­ca­tion for an un­der-the-skin main­te­nance dos­ing ver­sion of their Alzheimer’s treat­ment Leqem­bi. The sub­cu­ta­neous sub­mis­sion was

Patients with lower-risk myelodysplastic syndromes (MDS) who relapsed or were refractory to standard treatment achieved improved rates of red blood cell (RBC) transfusion independence with